Table 3.
Log-rank analysis for incidence of pacemaker-induced cardiomyopathy based on renal function status.
| eGFR | P |
|---|---|
| eGFR ≥ 90 mL/min/1.73 m2 (control) | |
| eGFR ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2 | 0.90 |
| eGFR > 30 mL/min/1.73 m2 and < 60 mL/min/1.73 m2 | 0.64 |
| eGFR ≤ 30 mL/min/1.73 m2 | 0.21 |
| eGFR ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2 (control) | |
| eGFR > 30 mL/min/1.73 m2 and < 60 mL/min/1.73 m2 | 0.90 |
| eGFR ≤ 30 mL/min/1.73 m2 | 0.02* |
| eGFR > 30 mL/min/1.73 m2 and < 60 mL/min/1.73 m2 (control) | |
| eGFR ≤ 30 mL/min/1.73 m2 | < 0.01** |
eGFR estimated glomerular filtration rate. *P < 0.05; **P < 0.01.